CMS reinstates enforcement discretion under CLIA for certain SARS-CoV-2 tests
During the COVID-19 public health emergency, the Centers for Medicare & Medicaid Services will continue to exercise enforcement discretion under the Clinical Laboratory Improvement Amendments to allow providers to test asymptomatic individuals using certain point-of-care SARS-CoV-2 tests authorized for symptomatic individuals, the Centers for Medicare & Medicaid Services announced Friday. The decision rescinds a Sept. 26 memorandum that ended the 2020 enforcement discretion policy.
Related News Articles
Headline
New research from the Center for Disease Control and Prevention indicates that by early fall 2022, an overwhelming percentage of American adults had…
Headline
The Centers for Medicare & Medicaid Services May 31 released regulatory changes to the COVID-19 health care staff vaccination requirements and long-term…
#HealthCareInnovation Blog
In the fall of 2021, two years into the COVID-19 pandemic in the U.S., nearly 80% of adults said they had heard “at least one of eight different false…
Headline
A new AHA report highlights key takeaways from nearly 350 health care professionals nationwide who participated in a series of AHA-hosted listening…
Headline
The National Institute for Occupational Safety and Health this week revoked eight N95 filtering facepiece respirator approvals and four powered air-…
Headline
As summer Pride parades and other large gatherings approach, Americans at high risk for mpox (monkeypox) exposure should ensure they are fully vaccinated with…